Centers for Disease Control and Prevention: A Scientific Foundation for Implementing Genomics and Precision Medicine Applications in Cancer Control and Prevention

疾病控制和预防中心：在癌症控制和预防中实施基因组学和精准医学应用的科学基础

• 批准号: 10034126
• 负责人: Michael Bowen
• 金额: $ 17.5万
• 依托单位: NATIONAL CANCER INSTITUTE
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10034126
• 关键词: Advanced Malignant Neoplasm; Agreement; Benchmarking; Cancer Burden; Cancer Control; Centers for Disease Control and Prevention (U.S.); Clinical; Collaborations; Communication; Consultations; Division of Cancer Control and Population Sciences; Evaluation; Foundations; General Population; Genomic medicine; Genomics; Health; Health Personnel; Healthcare; Population; Public Health; Resources; Training; Translating; cancer genomics; cancer prevention; mortality; population health; precision medicine; precision oncology; programs; tool

The purpose of this agreement is to effectively translate and responsibly advance cancer genomics and precision medicine into clinical and public health programs that can reduce the burden of cancer occurrence and mortality in the US. Under the terms of this agreement, the Office of Public Health Genomics will provide technical assistance and collaborations to the Division of Cancer Control and Population Sciences to 1) identify and disseminate information about emerging cancer genomic and precision medicine applications; 2) strengthen healthcare-public health collaborations and partnerships in translating evidence into clinical and public health action; 3) develop and disseminate tools and resources to help integrate cancer genomics into programs, 4) conduct evidence evaluations and health impact analyses for best practices and ways of implementation; 5) develop population metrics and indicators for successful integration of cancer precision medicine and genomics into population health programs; 6) provide training and consultation to public health departments and health care providers; 7) develop communication products to public health and healthcare providers and to the general public.

该协议的目的是有效地将癌症基因组学和精准医学转化为临床和公共卫生项目，并负责任地推进这些项目，从而减少美国癌症发病率和死亡率的负担。根据该协议条款，公共卫生基因组学办公室将向癌症控制和人口科学部提供技术援助和合作，以1)识别和传播有关新兴癌症基因组学和精准医学应用的信息；2)加强卫生保健-公共卫生合作和伙伴关系，将证据转化为临床和公共卫生行动；3)开发和传播工具和资源，以帮助将癌症基因组学整合到项目中；4)为最佳实践和实施方式进行证据评估和健康影响分析；5)为癌症精准医学和基因组学成功整合到人口健康计划中制定人口指标；6)向公共卫生部门和卫生保健提供者提供培训和咨询；7)开发面向公共卫生和医疗保健提供者以及公众的通信产品。